Buy Sonata Software Ltd For Target Rs.835 - ICICI Direct
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/03/b951e68f91d042f99bcfa2257b81f4df.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Aiming to reach, half a billion-dollar IT services revenues by FY26/27, acquires Quant systems
About the stock: Sonata Software (Sonata) offers IT services (30%) and product licensing & deployment (70%).
* The company provides IT services to travel, retail, agri & commodities and manufacturing and software vendors
* Net debt free and healthy double digit return ratio (with RoCE of >30%)
Key Highlights:
* years based on certain milestones.
* The acquisition is in line with Sonata’a strategy to accelerate IT services growth from hereon as well as strengthening its offering in BFSI and Healthcare vertical
* Quant Systems’s revenue grew 4x in last 2 years and growth going forward is also expected to be strong. EBITDA margins for the company are also healthy i.e., upwards of 30%.
What should investors do? Sonata’s share price has grown by ~3x over the past five years (from ~| 238 in February 2018 to ~| 706 levels in February 2023).
* We maintain our BUY rating on the stock
Target Price and Valuation: We value Sonata at | 835 i.e., 18x P/E on FY25E EPS.
Key triggers for future price performance:
* Acquisition of QS will strengthen Sonata offering in BFSI and Healthcare & Life science verticals which will aid the revenue growth of company
* It will also help in commanding better pricing as Quant Systems led data analytics, data engineering is already commanding premium billing rates
* Winning large deals and strong digital spending by the clients prompt us to build IT service dollar revenue growth of over 23.8% CAGR over FY22-25E
Alternate Stock Idea: Apart from Sonata, in our IT coverage we also like Infosys
* Key beneficiary of improved digital demand, industry leading revenue growth and healthy capital allocation prompt us to be positive
* BUY with a target price of | 1,730
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
SEBI Registration number is INZ000183631
Above views are of the author and not of the website kindly read disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/Ajmera Realty.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Pharma Sector 56.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/MoU Signing (1) 23.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Gv_Hotel.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/ShaktikantDas080324.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Realestate04.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Maruti Suzuki 25.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/FMCG4.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arpit Mehrotra, Managing Director, Office services, India, Colliers.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Finance.jpg)